Adjunct Study of Natrelle(TM) Cohesive Round Silicone-Filled Breast Implants
This study is ongoing, but not recruiting participants.
Sponsor:
Allergan Medical
Information provided by (Responsible Party):
Allergan Medical
ClinicalTrials.gov Identifier:
NCT00691327
First received: June 3, 2008
Last updated: December 12, 2012
Last verified: December 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Safety and effectiveness of Natrelle™ Cohesive Round Silicone-Filled Breast Implants in women undergoing primary reconstruction or revision of existing breast implants.
| Condition | Intervention |
|---|---|
|
Breast Reconstruction |
Device: Natrelle(TM) Silicone-Filled Breast Implants |
| Study Type: | Interventional |
| Study Design: | Allocation: Non-Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label |
| Official Title: | Adjunct Study of Natrelle(TM) Cohesive Round Silicone-Filled Breast Implants |
Resource links provided by NLM:
Further study details as provided by Allergan Medical:
Primary Outcome Measures:
- Local complications [ Time Frame: 5 years ] [ Designated as safety issue: Yes ]
Secondary Outcome Measures:
- Satisfaction determined by patients and physicians [ Time Frame: 5 years ] [ Designated as safety issue: No ]
| Enrollment: | 83091 |
| Study Start Date: | December 1997 |
| Estimated Study Completion Date: | December 2012 |
| Estimated Primary Completion Date: | December 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: 1
Primary reconstruction
|
Device: Natrelle(TM) Silicone-Filled Breast Implants
Breast implant surgery
|
|
Experimental: 2
Revision-reconstruction
|
Device: Natrelle(TM) Silicone-Filled Breast Implants
Breast implant surgery
|
|
Experimental: 3
Revision-augmentation
|
Device: Natrelle(TM) Silicone-Filled Breast Implants
Breast implant surgery
|
Eligibility| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- Females of any age for which breast reconstruction is considered appropriate (Patients under 18 years old require parental/legal guardian consent to participate.
- Females seeking revision augmentation or revision reconstruction, where problems exist
- Have any of the following conditions or situations present:
- Post mastectomy surgical removal of the breast for cancer or other disease;
- Post trauma or post surgery where there was total or partial removal of the breast resulting in significant deformity;
- Severe ptosis requiring reconstruction;
- Any congenital or acquired discrepancy in breast size such as to represent a significant physical deformity.
- Adequate tissue available to cover implants.
- Saline-filled implants are not an appropriate choice.
Exclusion Criteria:
- Advanced fibrocystic disease considered to be premalignant without accompanying subcutaneous mastectomy.
- Existing carcinoma of the breast, without mastectomy.
- Abscess of infection in the body at the time of enrollment.
- Pregnant or nursing.
- Have any disease, including uncontrolled diabetes, which is clinically known to impact wound healing ability.
- Show tissue characteristics which are clinically incompatible with mammaplasty.
- Have, or under treatment for any condition which, in the opinion of the surgeon, may constitute an unwarranted surgical risk.
- Are not willing to undergo further surgery for revision, if medically required.
- Diagnosis of lupus or scleroderma.
Contacts and Locations
More Information
No publications provided
| Responsible Party: | Allergan Medical |
| ClinicalTrials.gov Identifier: | NCT00691327 History of Changes |
| Other Study ID Numbers: | 910044 |
| Study First Received: | June 3, 2008 |
| Last Updated: | December 12, 2012 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Allergan Medical:
|
Revision of augmentation or reconstruction |
ClinicalTrials.gov processed this record on May 23, 2013